Non-Small Cell Lung Cancer May 10, 2023A Study of N-803 in Combination with Current Standard of Care vs Standard of Care as First-Line Treatment for Patients With Stage 3 or 4 NSCLC.
BCG Naïve NMIBC May 10, 2023A Study of Intravesical BCG in Combination With ALT-803 in BCG Naïve Patients with High-Grade, Non-Muscle Invasive Bladder Cancer
BCG Unresponsive NMIBC Carcinoma In-Situ & Papillary May 10, 2023A Multicenter Clinical Trial of Intravesical Bacillus Calmette-Guerin (BCG) in Combination With ALT-803 in Patients with BCG Unresponsive High Grade, Non-Muscle Invasive Bladder Cancer
